Miller, M. L., Griepp, D. W., Sun, Y., Tamir, S., Farber, R. S., Otten, M. L., & Al‐Dalahmah, O. (2022). A 53‐year‐old woman with a rapidly progressive, non‐enhancing left frontotemporal lesion. Brain Pathology, 33(2). Portico. https://doi.org/10.1111/bpa.13125

Avila-Rieger, J., Turney, I. C., Vonk, J. M. J., Esie, P., Seblova, D., Weir, V. R., Belsky, D. W., & Manly, J. J. (2022). Socioeconomic Status, Biological Aging, and Memory in a Diverse National Sample of Older US Men and Women. Neurology, 99(19). https://doi.org/10.1212/wnl.0000000000201032

Pichet Binette, A., Franzmeier, N., Spotorno, N., Ewers, M., Brendel, M., Biel, D., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., Beckett, L., Green, R. C., Saykin, A. J., Morris, J., Shaw, L. M., … Hansson, O. (2022). Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-34129-4

Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M.-E., Aguzzi, A., Ajami, B., Amit, I., Audinat, E., Bechmann, I., Bennett, M., Bennett, F., Bessis, A., Biber, K., Bilbo, S., Blurton-Jones, M., Boddeke, E., Brites, D., Brône, B., Brown, G. C., … Wyss-Coray, T. (2022). Microglia states and nomenclature: A field at its crossroads. Neuron, 110(21), 3458–3483. https://doi.org/10.1016/j.neuron.2022.10.020

Reyes, A., Hermann, B. P., Busch, R. M., Drane, D. L., Barr, W. B., Hamberger, M. J., Roesch, S. C., & McDonald, C. R. (2022). Moving towards a taxonomy of cognitive impairments in epilepsy: application of latent profile analysis to 1178 patients with temporal lobe epilepsy. Brain Communications, 4(6). https://doi.org/10.1093/braincomms/fcac289

Pan, P., Joanta-Gomez, A., Yuen, C., Donovan, L., Haggiagi, A., Welch, M., Iwamoto, F., & Lassman, A. (2022). NCOG-24. TIME TO FIRST RECURRENCE AND SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA. Neuro-Oncology, 24(Supplement_7), vii202–vii202. https://doi.org/10.1093/neuonc/noac209.776

Donovan, L., Joanta-Gomez, A., Furnari, J., Mouton, B., & Lassman, A. (2022). QOL-01. RISK FACTORS FOR AND CONSEQUENCES OF PROLONGED DEXAMETHASONE USE IN PATIENTS WITH GLIOBLASTOMA (GBM). Neuro-Oncology, 24(Supplement_7), vii240–vii240. https://doi.org/10.1093/neuonc/noac209.929

Bosc, E., Anastasie, J., Soualmia, F., Coric, P., Kim, J. Y., Wang, L. Q., Lacin, G., Zhao, K., Patel, R., Duplus, E., Tixador, P., Sproul, A. A., Brugg, B., Reboud-Ravaux, M., Troy, C. M., Shelanski, M. L., Bouaziz, S., Karin, M., El Amri, C., & Jacotot, E. D. (2022). Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics. Cell Death & Disease, 13(11). https://doi.org/10.1038/s41419-022-05396-2

Soto, E., Chapman, S., Turney, I., Zahodne, L., Cosentino, S., Brickman, A., Vonk, J., & Manly, J. (2022). LANGUAGE-BASED DISCRIMINATION RELATES TO MEMORY COMPLAINTS AMONG LATINX/HISPANIC OLDER ADULTS. Innovation in Aging, 6(Supplement_1), 349–350. https://doi.org/10.1093/geroni/igac059.1384

Paradkar, M. S., Devaleenal D, B., Mvalo, T., Arenivas, A., Thakur, K. T., Wolf, L., Nimkar, S., Inamdar, S., Giridharan, P., Selladurai, E., Kinikar, A., Valvi, C., Khwaja, S., Gadama, D., Balaji, S., Yadav Kattagoni, K., Venkatesan, M., Savic, R., Swaminathan, S., … Phillips, P. (2022). Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial. Clinical Infectious Diseases, 75(9), 1594–1601. https://doi.org/10.1093/cid/ciac208

Spinazzi, E. F., Argenziano, M. G., Upadhyayula, P. S., Banu, M. A., Neira, J. A., Higgins, D. M. O., Wu, P. B., Pereira, B., Mahajan, A., Humala, N., Al-Dalahmah, O., Zhao, W., Save, A. V., Gill, B. J. A., Boyett, D. M., Marie, T., Furnari, J. L., Sudhakar, T. D., Stopka, S. A., … Bruce, J. N. (2022). Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial. The Lancet Oncology, 23(11), 1409–1418. https://doi.org/10.1016/s1470-2045(22)00599-x

Elkind, M. S. V., & Hankey, G. J. (2022). Advances in Epidemiology, Outcomes, and Population Science. Stroke, 53(11), 3481–3484. https://doi.org/10.1161/strokeaha.122.039313

Joseph‐Mathurin, N., Llibre‐Guerra, J. J., Li, Y., McCullough, A. A., Hofmann, C., Wojtowicz, J., Park, E., Wang, G., Preboske, G. M., Wang, Q., Gordon, B. A., Chen, C. D., Flores, S., Aggarwal, N. T., Berman, S. B., Bird, T. D., Black, S. E., Borowski, B., … Brooks, W. S. (2022). Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Annals of Neurology, 92(5), 729–744. Portico. https://doi.org/10.1002/ana.26511

Kamitaki, B. K., Zhang, P., Master, A., Adler, S., Jain, S., Thomas-Hawkins, C., Lin, H., Cantor, J. C., & Choi, H. (2022). Differences in elective epilepsy monitoring unit admission rates by race/ethnicity and primary payer in New Jersey. Epilepsy & Behavior, 136, 108923. https://doi.org/10.1016/j.yebeh.2022.108923

Castano, V. G., Spotnitz, M., Waldman, G. J., Joiner, E. F., Choi, H., Ostropolets, A., Natarajan, K., McKhann, G. M., Ottman, R., Neugut, A. I., Hripcsak, G., & Youngerman, B. E. (2022). Identification of patients with drug‐resistant epilepsy in electronic medical record data using the Observational Medical Outcomes Partnership Common Data Model. Epilepsia, 63(11), 2981–2993. Portico. https://doi.org/10.1111/epi.17409

Kann, M., Chapman, S., Azar, M., Joyce, J., Waltrip, L., Shagalow, S., Rizer, S., & Cosentino, S. (2022). INVESTIGATION INTO THE PREDICTORS OF HELP-SEEKING BEHAVIOR IN OLDER ADULTS. Innovation in Aging, 6(Supplement_1), 529–529. https://doi.org/10.1093/geroni/igac059.2015

Minns, H., Padilla, O., Wei, H.-J., Webster-Carrion, A., Tazhibi, M., McQuillan, N., Zhang, X., Yeh, R., Zhang, Z., Szalontay, L., Pavisic, J., Garty, G., Garvin, J., Canoll, P., Vanpouille-Box, C., Menon, V., Olah, M., Rabadan, R., Wu, C.-C., & Gartrell, R. (2022). TMIC-68. EVALUATING FLASH AND CONVENTIONAL DOSE-RATE RADIATION AND IMMUNE RESPONSE WITH SINGLE-CELL SEQUENCING IN DIFFUSE MIDLINE GLIOMA (DMG). Neuro-Oncology, 24(Supplement_7), vii286–vii286. https://doi.org/10.1093/neuonc/noac209.1111

McMillan, C. T., Wuu, J., Rascovsky, K., Cosentino, S., Grossman, M., Elman, L., Quinn, C., Rosario, L., Stark, J. H., Granit, V., Briemberg, H., Chenji, S., Dionne, A., Genge, A., Johnston, W., Korngut, L., Shoesmith, C., Zinman, L., … Benatar, M. (2022). Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 23(7–8), 517–526. https://doi.org/10.1080/21678421.2022.2039713

Vitale, F., Gelinas, J. N., & Cabrera, L. Y. (2022). Neurotechnology: Bridging the dialogue between engineers, material scientists, clinicians, and ethicists. IScience, 25(11), 105432. https://doi.org/10.1016/j.isci.2022.105432

Tobochnik, S., Bateman, L. M., Akman, C. I., Anbarasan, D., Bazil, C. W., Bell, M., Choi, H., Feldstein, N. A., Kent, P. F., McBrian, D., McKhann, G. M., Mendiratta, A., Pack, A. M., Sands, T. T., Sheth, S. A., Srinivasan, S., & Schevon, C. A. (2021). Tracking Multisite Seizure Propagation Using Ictal High-Gamma Activity. Journal of Clinical Neurophysiology, 39(7), 592–601. https://doi.org/10.1097/wnp.0000000000000833

Jun, G. R., You, Y., Zhu, C., Meng, G., Chung, J., Panitch, R., Hu, J., Xia, W., Bennett, D. A., Foroud, T. M., Wang, L., Haines, J. L., Mayeux, R., Pericak‐Vance, M. A., Schellenberg, G. D., Au, R., Lunetta, K. L., Ikezu, T., … Farrer, L. A. (2022). Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer’s disease. Alzheimer’s & Dementia, 18(11), 2042–2054. Portico. https://doi.org/10.1002/alz.12607

Picard, M., & Shirihai, O. S. (2022). Mitochondrial signal transduction. Cell Metabolism, 34(11), 1620–1653. https://doi.org/10.1016/j.cmet.2022.10.008

Kwon, C.-S., Wirrell, E. C., & Jetté, N. (2022). Autism Spectrum Disorder and Epilepsy. Neurologic Clinics, 40(4), 831–847. https://doi.org/10.1016/j.ncl.2022.03.011

Clark, L. N., Gao, Y., Wang, G. T., Hernandez, N., Ashley-Koch, A., Jankovic, J., Ottman, R., Leal, S. M., Rodriguez, S. M. B., & Louis, E. D. (2022). Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology. EBioMedicine, 85, 104290. https://doi.org/10.1016/j.ebiom.2022.104290

Ostrowitzki, S., Bittner, T., Sink, K. M., Mackey, H., Rabe, C., Honig, L. S., Cassetta, E., Woodward, M., Boada, M., van Dyck, C. H., Grimmer, T., Selkoe, D. J., Schneider, A., Blondeau, K., Hu, N., Quartino, A., Clayton, D., Dolton, M., Dang, Y., … Doody, R. S. (2022). Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease. JAMA Neurology, 79(11), 1113. https://doi.org/10.1001/jamaneurol.2022.2909

Pitt, D., Lo, C. H., Gauthier, S. A., Hickman, R. A., Longbrake, E., Airas, L. M., Mao-Draayer, Y., Riley, C., De Jager, P. L., Wesley, S., Boster, A., Topalli, I., Bagnato, F., Mansoor, M., Stuve, O., Kister, I., Pelletier, D., Stathopoulos, P., Dutta, R., & Lincoln, M. R. (2022). Toward Precision Phenotyping of Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation, 9(6). https://doi.org/10.1212/nxi.0000000000200025

Wen, P. Y., Reardon, D. A., Forst, D., Lee, E., Daoud, T., Berthoud, T., Soare, C., Diaz-Mitoma, F., Anderson, D. E., Lassman, A., & Iwamoto, F. (2022). CTIM-14. COMPREHENSIVE BIOMARKER ANALYSIS OF RESPONDERS AND NON-RESPONDERS IN A PHASE IIA TRIAL OF A CMV VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901). Neuro-Oncology, 24(Supplement_7), vii62–vii62. https://doi.org/10.1093/neuonc/noac209.246

Chiriboga, C. A. (2022). Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental Therapies. Pediatric Drugs, 24(6), 585–602. https://doi.org/10.1007/s40272-022-00529-8

Arrillaga-Romany, I., Lassman, A., McGovern, S., Mueller, S., Nabors, L. B., van den Bent, M., Vogelbaum, M., Allen, J. E., Melemed, A., Tarapore, R., Yang, D., Wen, P. Y., & Cloughesy, T. (2022). RTID-01. ONC108: A RANDOMIZED PHASE 3 STUDY OF ONC201 IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA. Neuro-Oncology, 24(Supplement_7), vii249–vii249. https://doi.org/10.1093/neuonc/noac209.961

Samtani, S., Mahalingam, G., Lam, B. C. P., Lipnicki, D. M., Lima-Costa, M. F., Blay, S. L., Castro-Costa, E., Shifu, X., Guerchet, M., Preux, P.-M., Gbessemehlan, A., Skoog, I., Najar, J., Rydberg Sterner, T., Scarmeas, N., Kim, K.-W., Riedel-Heller, S., Röhr, S., Pabst, A., … Brodaty, H. (2022). Associations between social connections and cognition: a global collaborative individual participant data meta-analysis. The Lancet Healthy Longevity, 3(11), e740–e753. https://doi.org/10.1016/s2666-7568(22)00199-4

Ellingson, B., Wen, P. Y., Chang, S., van den Bent, M., Vogelbaum, M., Li, G., Li, S., Kim, J., Youssef, G., Wick, W., Lassman, A., Gilbert, M., de Groot, J., Weller, M., Galanis, E., & Cloughesy, T. (2022). NIMG-42. DURABLE OVERALL RESPONSE RATE (ORR) TARGETS FOR RECURRENT GLIOBLASTOMA (RGBM) CLINICAL TRIALS BASED ON THE HISTORIC ASSOCIATION BETWEEN ORR AND MEDIAN OVERALL SURVIVAL (MOS). Neuro-Oncology, 24(Supplement_7), vii172–vii173. https://doi.org/10.1093/neuonc/noac209.660

Hu, J., Waters, C. H., Spiegelman, D., Fon, E. A., Yu, E., Asayesh, F., Krohn, L., Saini, P., Alcalay, R. N., Hassin-Baer, S., Gan-Or, Z., Krainc, D., Zhang, B., Bustos, B. I., & Lubbe, S. J. (2022). Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson’s disease cohorts of European descent. Neurobiology of Aging, 119, 136–138. https://doi.org/10.1016/j.neurobiolaging.2022.07.012

Pan, X., Zhang, D., Heo, J. H., Park, C., Li, G., Dengler-Crish, C. M., Li, Y., Gu, Y., Young, H. N., Lavender, D. L., & Shi, L. (2022). Antihypertensive Use and the Risk of Alzheimer’s Disease and Related Dementias among Older Adults in the USA. Drugs & Aging, 39(11), 875–886. https://doi.org/10.1007/s40266-022-00981-8

Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., Saab, G., & Shah, P. (2022). Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3. Neurology Neuroimmunology & Neuroinflammation, 9(6). https://doi.org/10.1212/nxi.0000000000200032

Mishra, A., Malik, R., Hachiya, T., Jürgenson, T., Namba, S., Posner, D. C., Kamanu, F. K., Koido, M., Le Grand, Q., Shi, M., He, Y., Georgakis, M. K., Caro, I., Krebs, K., Liaw, Y.-C., Vaura, F. C., Lin, K., Winsvold, B. S., Srinivasasainagendra, V., … Debette, S. (2022). Stroke genetics informs drug discovery and risk prediction across ancestries. Nature, 611(7934), 115–123. https://doi.org/10.1038/s41586-022-05165-3

Russo, G. B., Goyal, T., Tyler, K., & Thakur, K. T. (2022). Re‐Emergence of Poliovirus in the United States: Considerations and Implications. Annals of Neurology, 92(5), 725–728. Portico. https://doi.org/10.1002/ana.26504

Buxton, M., Alexander, B., Berry, D., Cavenee, W., Colman, H., de Groot, J., Ellingson, B., Gordon, G., Khasraw, M., Lassman, A., Lee, E., Li, W., Lim, M., Mellinghoff, I., Mikkelsen, T., Nelli, A., Perry, J., Sulman, E., Tanner, K., … Cloughesy, T. (2022). CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology, 24(Supplement_7), vii80–vii80. https://doi.org/10.1093/neuonc/noac209.303

Hussain, S., Nawaz, S., Khan, H., Acharya, A., Schrauwen, I., Ahmad, W., & Leal, S. M. (2022). A splice site variant in TCTN3 underlies an atypical form of orofaciodigital syndrome IV. Annals of Human Genetics, 86(6), 291–296. Portico. https://doi.org/10.1111/ahg.12462

Constant, A. B., Basavaraju, R., France, J., Honig, L. S., Marder, K. S., & Provenzano, F. A. (2022). Longitudinal Patterns of Cortical Atrophy on MRI in Patients With Alzheimer Disease With and Without Lewy Body Pathology. Neurology, 99(17). https://doi.org/10.1212/wnl.0000000000200947

Simuni, T., Merchant, K., Brumm, M. C., Cho, H., Caspell-Garcia, C., Coffey, C. S., Chahine, L. M., Alcalay, R. N., Nudelman, K., Foroud, T., Mollenhauer, B., Siderowf, A., Tanner, C., Iwaki, H., Sherer, T., Marek, K., Siderowf, A., … Tauscher, J. (2022). Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort. Npj Parkinson’s Disease, 8(1). https://doi.org/10.1038/s41531-022-00404-w

Bhattarai, P., Turgutalp, B., & Kizil, C. (2022). Zebrafish as an Experimental and Preclinical Model for Alzheimer’s Disease. ACS Chemical Neuroscience, 13(20), 2939–2941. https://doi.org/10.1021/acschemneuro.2c00583

Aber, E. R., Griffey, C. J., Davies, T., Li, A. M., Yang, Y. J., Croce, K. R., Goldman, J. E., Grutzendler, J., Canman, J. C., & Yamamoto, A. (2022). Oligodendroglial macroautophagy is essential for myelin sheath turnover to prevent neurodegeneration and death. Cell Reports, 41(3), 111480. https://doi.org/10.1016/j.celrep.2022.111480

Dumais, F., Caceres, M. P., Janelle, F., Seifeldine, K., Arès-Bruneau, N., Gutierrez, J., Bocti, C., & Whittingstall, K. (2022). eICAB: A novel deep learning pipeline for Circle of Willis multiclass segmentation and analysis. NeuroImage, 260, 119425. https://doi.org/10.1016/j.neuroimage.2022.119425

Chen, J., Wang, L., De Jager, P. L., Bennett, D. A., Buchman, A. S., & Yang, J. (2022). A scalable Bayesian functional GWAS method accounting for multivariate quantitative functional annotations with applications for studying Alzheimer disease. Human Genetics and Genomics Advances, 3(4), 100143. https://doi.org/10.1016/j.xhgg.2022.100143

Song, S., Gaynor, A. M., Gazes, Y., Lee, S., Xu, Q., Habeck, C., Stern, Y., & Gu, Y. (2022). Physical activity moderates the association between white matter hyperintensity burden and cognitive change. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.945645

Mosharov, E. V., & Lindau, M. (2022). Patch Amperometry and Intracellular Patch Electrochemistry. Chromaffin Cells, 239–260. https://doi.org/10.1007/978-1-0716-2671-9_17

Lee, B. H., Deng, S., Chiriboga, C. A., Kay, D. M., Irumudomon, O., Laureta, E., Delfiner, L., Treidler, S. O., Anziska, Y., Sakonju, A., Kois, C., Farooq, O., Engelstad, K., Laurenzano, A., Hogan, K., Caggana, M., Saavedra-Matiz, C. A., Stevens, C. F., & Ciafaloni, E. (2022). Newborn Screening for Spinal Muscular Atrophy in New York State. Neurology, 99(14). https://doi.org/10.1212/wnl.0000000000200986

Owyang, C. G., Abualsaud, R., Agarwal, S., Del Rios, M., Grossestreuer, A. V., Horowitz, J. M., Johnson, N. J., Kotini‐Shah, P., Mitchell, O. J. L., Morgan, R. W., Moskowitz, A., Perman, S. M., Rittenberger, J. C., Sawyer, K. N., Yuriditsky, E., Abella, B. S., & Teran, F. (2022). Latest in Resuscitation Research: Highlights From the 2021 American Heart Association’s Resuscitation Science Symposium. Journal of the American Heart Association, 11(19). https://doi.org/10.1161/jaha.122.026191

Chapman, S., Weiss, D., Broulíková, H. M., Sunderaraman, P., Barker, M. S., Joyce, J. L., Azar, M., McKeague, I., Kriesl, W. C., & Cosentino, S. (2022). Examining the Role of Aging Perceptions in Subjective Cognitive Decline. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/wad.0000000000000518